These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11330322)

  • 41. War against anthrax.
    Khanna H; Singh Y
    Mol Med; 2001 Dec; 7(12):795-6. PubMed ID: 11844866
    [No Abstract]   [Full Text] [Related]  

  • 42. Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine.
    Komiyama T; Swanson JA; Fuller RS
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3875-82. PubMed ID: 16127065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designing a polyvalent inhibitor of anthrax toxin.
    Mourez M; Kane RS; Mogridge J; Metallo S; Deschatelets P; Sellman BR; Whitesides GM; Collier RJ
    Nat Biotechnol; 2001 Oct; 19(10):958-61. PubMed ID: 11581662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis.
    Sun DS; Chang YW; Kau JH; Huang HH; Ho PH; Tzeng YJ; Chang HH
    Virulence; 2017 Oct; 8(7):1216-1228. PubMed ID: 28102766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis.
    Abrami L; Leppla SH; van der Goot FG
    J Cell Biol; 2006 Jan; 172(2):309-20. PubMed ID: 16401723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
    Krantz BA; Finkelstein A; Collier RJ
    J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional characterization of peptide-based anthrax toxin inhibitors.
    Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
    Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of small molecule inhibitors of anthrax lethal factor.
    Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
    Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241.
    Palmer J; Bell M; Darko C; Barnewall R; Keane-Myers A
    Pathog Dis; 2014 Nov; 72(2):138-42. PubMed ID: 25044336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
    Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.
    Bai JP; Sakellaropoulos T; Alexopoulos LG
    Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28287432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three steps to targeting anthrax toxin.
    Lindsay J
    Trends Mol Med; 2002 Jan; 8(1):6. PubMed ID: 11796256
    [No Abstract]   [Full Text] [Related]  

  • 55. Microbiology. A binding contract for anthrax.
    Bull JJ; Parrish CR
    Science; 2002 Jul; 297(5579):201-2. PubMed ID: 12114612
    [No Abstract]   [Full Text] [Related]  

  • 56. Symmetry complementarity-guided design of anthrax toxin inhibitors based on β-cyclodextrin: Synthesis and relative activities of face-selective functionalized polycationic clusters.
    Díaz-Moscoso A; Méndez-Ardoy A; Ortega-Caballero F; Benito JM; Ortiz Mellet C; Defaye J; Robinson TM; Yohannes A; Karginov VA; García Fernández JM
    ChemMedChem; 2011 Jan; 6(1):181-92. PubMed ID: 21140396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
    Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN
    Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
    Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
    J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring endocytic trafficking of anthrax lethal factor by precise and quantitative protein labeling.
    Zheng S; Zhang G; Li J; Chen PR
    Angew Chem Int Ed Engl; 2014 Jun; 53(25):6449-53. PubMed ID: 24828812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation.
    Melnyk RA; Collier RJ
    Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9802-7. PubMed ID: 16785422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.